Global Anti-obesity Drugs Market Research Report 2024

Report ID: 1983316 | Published Date: Jan 2025 | No. of Page: 97 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Anti-obesity Drugs Market Overview
    1.1 Product Overview and Scope of Anti-obesity Drugs
    1.2 Anti-obesity Drugs Segment by Type
        1.2.1 Global Anti-obesity Drugs Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Peripherally Acting Anti-obesity Drugs
        1.2.3 Centrally Acting Anti-obesity Drugs
    1.3 Anti-obesity Drugs Segment by Application
        1.3.1 Global Anti-obesity Drugs Sales Comparison by Application: (2022-2028)
        1.3.2 Kids
        1.3.3 Adults
    1.4 Global Anti-obesity Drugs Market Size Estimates and Forecasts
        1.4.1 Global Anti-obesity Drugs Revenue 2017-2028
        1.4.2 Global Anti-obesity Drugs Sales 2017-2028
        1.4.3 Anti-obesity Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Anti-obesity Drugs Market Competition by Manufacturers
    2.1 Global Anti-obesity Drugs Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Anti-obesity Drugs Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Anti-obesity Drugs Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Anti-obesity Drugs Manufacturing Sites, Area Served, Product Type
    2.5 Anti-obesity Drugs Market Competitive Situation and Trends
        2.5.1 Anti-obesity Drugs Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Anti-obesity Drugs Players Market Share by Revenue
        2.5.3 Global Anti-obesity Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-obesity Drugs Retrospective Market Scenario by Region
    3.1 Global Anti-obesity Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Anti-obesity Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Anti-obesity Drugs Market Facts & Figures by Country
        3.3.1 North America Anti-obesity Drugs Sales by Country
        3.3.2 North America Anti-obesity Drugs Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Anti-obesity Drugs Market Facts & Figures by Country
        3.4.1 Europe Anti-obesity Drugs Sales by Country
        3.4.2 Europe Anti-obesity Drugs Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Anti-obesity Drugs Market Facts & Figures by Region
        3.5.1 Asia Pacific Anti-obesity Drugs Sales by Region
        3.5.2 Asia Pacific Anti-obesity Drugs Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Anti-obesity Drugs Market Facts & Figures by Country
        3.6.1 Latin America Anti-obesity Drugs Sales by Country
        3.6.2 Latin America Anti-obesity Drugs Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Anti-obesity Drugs Market Facts & Figures by Country
        3.7.1 Middle East and Africa Anti-obesity Drugs Sales by Country
        3.7.2 Middle East and Africa Anti-obesity Drugs Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Anti-obesity Drugs Historic Market Analysis by Type
    4.1 Global Anti-obesity Drugs Sales Market Share by Type (2017-2022)
    4.2 Global Anti-obesity Drugs Revenue Market Share by Type (2017-2022)
    4.3 Global Anti-obesity Drugs Price by Type (2017-2022)
5 Global Anti-obesity Drugs Historic Market Analysis by Application
    5.1 Global Anti-obesity Drugs Sales Market Share by Application (2017-2022)
    5.2 Global Anti-obesity Drugs Revenue Market Share by Application (2017-2022)
    5.3 Global Anti-obesity Drugs Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Merck
        6.1.1 Merck Corporation Information
        6.1.2 Merck Description and Business Overview
        6.1.3 Merck Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Merck Anti-obesity Drugs Product Portfolio
        6.1.5 Merck Recent Developments/Updates
    6.2 Novo Nordisk
        6.2.1 Novo Nordisk Corporation Information
        6.2.2 Novo Nordisk Description and Business Overview
        6.2.3 Novo Nordisk Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Novo Nordisk Anti-obesity Drugs Product Portfolio
        6.2.5 Novo Nordisk Recent Developments/Updates
    6.3 Pfizer
        6.3.1 Pfizer Corporation Information
        6.3.2 Pfizer Description and Business Overview
        6.3.3 Pfizer Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Pfizer Anti-obesity Drugs Product Portfolio
        6.3.5 Pfizer Recent Developments/Updates
    6.4 Arena Pharmaceuticals
        6.4.1 Arena Pharmaceuticals Corporation Information
        6.4.2 Arena Pharmaceuticals Description and Business Overview
        6.4.3 Arena Pharmaceuticals Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Arena Pharmaceuticals Anti-obesity Drugs Product Portfolio
        6.4.5 Arena Pharmaceuticals Recent Developments/Updates
    6.5 Roche
        6.5.1 Roche Corporation Information
        6.5.2 Roche Description and Business Overview
        6.5.3 Roche Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Roche Anti-obesity Drugs Product Portfolio
        6.5.5 Roche Recent Developments/Updates
    6.6 GlaxoSmithKline
        6.6.1 GlaxoSmithKline Corporation Information
        6.6.2 GlaxoSmithKline Description and Business Overview
        6.6.3 GlaxoSmithKline Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 GlaxoSmithKline Anti-obesity Drugs Product Portfolio
        6.6.5 GlaxoSmithKline Recent Developments/Updates
    6.7 Orexigen Therapeutics
        6.6.1 Orexigen Therapeutics Corporation Information
        6.6.2 Orexigen Therapeutics Description and Business Overview
        6.6.3 Orexigen Therapeutics Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Orexigen Therapeutics Anti-obesity Drugs Product Portfolio
        6.7.5 Orexigen Therapeutics Recent Developments/Updates
    6.8 Vivus
        6.8.1 Vivus Corporation Information
        6.8.2 Vivus Description and Business Overview
        6.8.3 Vivus Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Vivus Anti-obesity Drugs Product Portfolio
        6.8.5 Vivus Recent Developments/Updates
    6.9 Amylin
        6.9.1 Amylin Corporation Information
        6.9.2 Amylin Description and Business Overview
        6.9.3 Amylin Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Amylin Anti-obesity Drugs Product Portfolio
        6.9.5 Amylin Recent Developments/Updates
    6.10 Alizyme
        6.10.1 Alizyme Corporation Information
        6.10.2 Alizyme Description and Business Overview
        6.10.3 Alizyme Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Alizyme Anti-obesity Drugs Product Portfolio
        6.10.5 Alizyme Recent Developments/Updates
    6.11 Boehringer Ingelheim
        6.11.1 Boehringer Ingelheim Corporation Information
        6.11.2 Boehringer Ingelheim Anti-obesity Drugs Description and Business Overview
        6.11.3 Boehringer Ingelheim Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Boehringer Ingelheim Anti-obesity Drugs Product Portfolio
        6.11.5 Boehringer Ingelheim Recent Developments/Updates
    6.12 Eisai
        6.12.1 Eisai Corporation Information
        6.12.2 Eisai Anti-obesity Drugs Description and Business Overview
        6.12.3 Eisai Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Eisai Anti-obesity Drugs Product Portfolio
        6.12.5 Eisai Recent Developments/Updates
7 Anti-obesity Drugs Manufacturing Cost Analysis
    7.1 Anti-obesity Drugs Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Anti-obesity Drugs
    7.4 Anti-obesity Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Anti-obesity Drugs Distributors List
    8.3 Anti-obesity Drugs Customers
9 Anti-obesity Drugs Market Dynamics
    9.1 Anti-obesity Drugs Industry Trends
    9.2 Anti-obesity Drugs Market Drivers
    9.3 Anti-obesity Drugs Market Challenges
    9.4 Anti-obesity Drugs Market Restraints
10 Global Market Forecast
    10.1 Anti-obesity Drugs Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Anti-obesity Drugs by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Anti-obesity Drugs by Type (2023-2028)
    10.2 Anti-obesity Drugs Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Anti-obesity Drugs by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Anti-obesity Drugs by Application (2023-2028)
    10.3 Anti-obesity Drugs Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Anti-obesity Drugs by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Anti-obesity Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Anti-obesity Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Anti-obesity Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Anti-obesity Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Anti-obesity Drugs Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Anti-obesity Drugs Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Anti-obesity Drugs Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Anti-obesity Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Anti-obesity Drugs Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Anti-obesity Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Anti-obesity Drugs Manufacturing Sites and Area Served
    Table 11. Manufacturers Anti-obesity Drugs Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Anti-obesity Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-obesity Drugs as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Anti-obesity Drugs Sales by Region (2017-2022) & (K Units)
    Table 16. Global Anti-obesity Drugs Sales Market Share by Region (2017-2022)
    Table 17. Global Anti-obesity Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Anti-obesity Drugs Revenue Market Share by Region (2017-2022)
    Table 19. North America Anti-obesity Drugs Sales by Country (2017-2022) & (K Units)
    Table 20. North America Anti-obesity Drugs Sales Market Share by Country (2017-2022)
    Table 21. North America Anti-obesity Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Anti-obesity Drugs Revenue Market Share by Country (2017-2022)
    Table 23. Europe Anti-obesity Drugs Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Anti-obesity Drugs Sales Market Share by Country (2017-2022)
    Table 25. Europe Anti-obesity Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Anti-obesity Drugs Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Anti-obesity Drugs Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Anti-obesity Drugs Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Anti-obesity Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Anti-obesity Drugs Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Anti-obesity Drugs Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Anti-obesity Drugs Sales Market Share by Country (2017-2022)
    Table 33. Latin America Anti-obesity Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Anti-obesity Drugs Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Anti-obesity Drugs Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Anti-obesity Drugs Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Anti-obesity Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Anti-obesity Drugs Revenue Market Share by Country (2017-2022)
    Table 39. Global Anti-obesity Drugs Sales by Type (2017-2022) & (K Units)
    Table 40. Global Anti-obesity Drugs Sales Market Share by Type (2017-2022)
    Table 41. Global Anti-obesity Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Anti-obesity Drugs Revenue Share by Type (2017-2022)
    Table 43. Global Anti-obesity Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Anti-obesity Drugs Sales (K Units) by Application (2017-2022)
    Table 45. Global Anti-obesity Drugs Sales Market Share by Application (2017-2022)
    Table 46. Global Anti-obesity Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Anti-obesity Drugs Revenue Share by Application (2017-2022)
    Table 48. Global Anti-obesity Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 49. Merck Corporation Information
    Table 50. Merck Description and Business Overview
    Table 51. Merck Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Merck Anti-obesity Drugs Product
    Table 53. Merck Recent Developments/Updates
    Table 54. Novo Nordisk Corporation Information
    Table 55. Novo Nordisk Description and Business Overview
    Table 56. Novo Nordisk Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Novo Nordisk Anti-obesity Drugs Product
    Table 58. Novo Nordisk Recent Developments/Updates
    Table 59. Pfizer Corporation Information
    Table 60. Pfizer Description and Business Overview
    Table 61. Pfizer Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Pfizer Anti-obesity Drugs Product
    Table 63. Pfizer Recent Developments/Updates
    Table 64. Arena Pharmaceuticals Corporation Information
    Table 65. Arena Pharmaceuticals Description and Business Overview
    Table 66. Arena Pharmaceuticals Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Arena Pharmaceuticals Anti-obesity Drugs Product
    Table 68. Arena Pharmaceuticals Recent Developments/Updates
    Table 69. Roche Corporation Information
    Table 70. Roche Description and Business Overview
    Table 71. Roche Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Roche Anti-obesity Drugs Product
    Table 73. Roche Recent Developments/Updates
    Table 74. GlaxoSmithKline Corporation Information
    Table 75. GlaxoSmithKline Description and Business Overview
    Table 76. GlaxoSmithKline Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. GlaxoSmithKline Anti-obesity Drugs Product
    Table 78. GlaxoSmithKline Recent Developments/Updates
    Table 79. Orexigen Therapeutics Corporation Information
    Table 80. Orexigen Therapeutics Description and Business Overview
    Table 81. Orexigen Therapeutics Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 82. Orexigen Therapeutics Anti-obesity Drugs Product
    Table 83. Orexigen Therapeutics Recent Developments/Updates
    Table 84. Vivus Corporation Information
    Table 85. Vivus Description and Business Overview
    Table 86. Vivus Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 87. Vivus Anti-obesity Drugs Product
    Table 88. Vivus Recent Developments/Updates
    Table 89. Amylin Corporation Information
    Table 90. Amylin Description and Business Overview
    Table 91. Amylin Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 92. Amylin Anti-obesity Drugs Product
    Table 93. Amylin Recent Developments/Updates
    Table 94. Alizyme Corporation Information
    Table 95. Alizyme Description and Business Overview
    Table 96. Alizyme Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 97. Alizyme Anti-obesity Drugs Product
    Table 98. Alizyme Recent Developments/Updates
    Table 99. Boehringer Ingelheim Corporation Information
    Table 100. Boehringer Ingelheim Description and Business Overview
    Table 101. Boehringer Ingelheim Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 102. Boehringer Ingelheim Anti-obesity Drugs Product
    Table 103. Boehringer Ingelheim Recent Developments/Updates
    Table 104. Eisai Corporation Information
    Table 105. Eisai Description and Business Overview
    Table 106. Eisai Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 107. Eisai Anti-obesity Drugs Product
    Table 108. Eisai Recent Developments/Updates
    Table 109. Production Base and Market Concentration Rate of Raw Material
    Table 110. Key Suppliers of Raw Materials
    Table 111. Anti-obesity Drugs Distributors List
    Table 112. Anti-obesity Drugs Customers List
    Table 113. Anti-obesity Drugs Market Trends
    Table 114. Anti-obesity Drugs Market Drivers
    Table 115. Anti-obesity Drugs Market Challenges
    Table 116. Anti-obesity Drugs Market Restraints
    Table 117. Global Anti-obesity Drugs Sales Forecast by Type (2023-2028) & (K Units)
    Table 118. Global Anti-obesity Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 119. Global Anti-obesity Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 120. Global Anti-obesity Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 121. Global Anti-obesity Drugs Sales Forecast by Application (2023-2028) & (K Units)
    Table 122. Global Anti-obesity Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 123. Global Anti-obesity Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 124. Global Anti-obesity Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 125. Global Anti-obesity Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 126. Global Anti-obesity Drugs Sales Market Share Forecast by Region (2023-2028)
    Table 127. Global Anti-obesity Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 128. Global Anti-obesity Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 129. Research Programs/Design for This Report
    Table 130. Key Data Information from Secondary Sources
    Table 131. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Anti-obesity Drugs
    Figure 2. Global Anti-obesity Drugs Market Share by Type in 2021 & 2028
    Figure 3. Peripherally Acting Anti-obesity Drugs Product Picture
    Figure 4. Centrally Acting Anti-obesity Drugs Product Picture
    Figure 5. Global Anti-obesity Drugs Market Share by Application in 2021 & 2028
    Figure 6. Kids
    Figure 7. Adults
    Figure 8. Global Anti-obesity Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 9. Global Anti-obesity Drugs Market Size (2017-2028) & (US$ Million)
    Figure 10. Global Anti-obesity Drugs Sales (2017-2028) & (K Units)
    Figure 11. Anti-obesity Drugs Sales Share by Manufacturers in 2021
    Figure 12. Global Anti-obesity Drugs Revenue Share by Manufacturers in 2021
    Figure 13. The Global 5 and 10 Largest Anti-obesity Drugs Players: Market Share by Revenue in 2021
    Figure 14. Anti-obesity Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 15. Global Anti-obesity Drugs Sales Market Share by Region (2017-2022)
    Figure 16. Global Anti-obesity Drugs Sales Market Share by Region in 2021
    Figure 17. Global Anti-obesity Drugs Revenue Market Share by Region (2017-2022)
    Figure 18. Global Anti-obesity Drugs Revenue Market Share by Region in 2021
    Figure 19. U.S. Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 20. Canada Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Germany Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. France Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. U.K. Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Italy Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Russia Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. China Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Japan Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. South Korea Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. India Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Australia Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Taiwan Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Indonesia Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Thailand Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Malaysia Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Philippines Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Vietnam Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Mexico Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Brazil Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Argentina Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Turkey Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Saudi Arabia Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. U.A.E Anti-obesity Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Sales Market Share of Anti-obesity Drugs by Type (2017-2022)
    Figure 44. Manufacturing Cost Structure of Anti-obesity Drugs
    Figure 45. Manufacturing Process Analysis of Anti-obesity Drugs
    Figure 46. Anti-obesity Drugs Industrial Chain Analysis
    Figure 47. Channels of Distribution
    Figure 48. Distributors Profiles
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Novo Nordisk
Pfizer
Arena Pharmaceuticals
Roche
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Amylin
Alizyme
Boehringer Ingelheim
Eisai
Frequently Asked Questions
Anti-obesity Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Anti-obesity Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Anti-obesity Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Antiviral Drugs

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More